ADVFN - Advanced Financial Network.
HOME» NYSE » D » DVA Stock Price » DVA Stock News

Davita Share News

 Davita Inc. Stock Price
DVA Stock Price
 Davita Inc. Stock Chart
DVA Stock Chart
 Davita Inc. Stock News
DVA Stock News
 Davita Inc. Company Information
DVA Company Information
 Davita Inc. Stock Trades
DVA Stock Trades

DaVita To Sell $1.45 Billion Of Notes To Fund Debt-Refinance Plan

DOW JONES NEWSWIRES DaVita Inc. (DVA) plans to sell $1.45 billion of notes to fund the potential repurchase of up to $1.55 billion of debt as the operator of dialysis centers joins a host of companies looking to retire near-term borrowings with longer-data, and hopefully cheaper, debt. The length of the notes to be sold wasn't disclosed in a statement. In the tender offer are $700 million of 6 5/8% notes maturing in 2013 and $850 million of 7 1/4% notes due 2015. The company is offering 1.9% and 3.9% above face value, respectively, including an early tender premium. Sale of the new notes is contingent on closing new credit lines. DaVita last week announced a $3.35 billion debt-refinancing plan that besides the $1.55 billion of notes includes $1.8 billion of borrowings under senior credit lines. DaVita has seen earnings grow in recent quarters amid increasing demand. Last month, uncertainty that had jostled its share price for months was lifted as effects of a shift in Medicare and Medicaid reimbursement were clarified. The company's commentary on the changes was cautiously upbeat, according to an analyst. Shares closed at $69.03 Thursday and didn't trade premarket. Thos stock has risen 18% this year. -By Jodi Xu, Dow Jones Newswires; 212-416-3037;

Stock News for Davita (DVA)
11/24/201506:22:00DaVita Kidney Care Offers Fall Favorites Cookbook
11/18/201517:13:27Current Report Filing (8-k)
11/12/201517:54:53Statement of Changes in Beneficial Ownership (4)
11/06/201506:48:00Recipients of Bio-specimen Grant Program BioReG Announced During...
11/05/201507:22:56Quarterly Report (10-q)
11/03/201516:18:52Current Report Filing (8-k)
11/03/201516:03:00DaVita HealthCare Partners Inc. 3rd Quarter 2015 Results
10/29/201506:13:00Kidney-Friendly Tips and Treats for Halloween
10/23/201518:36:33Young And Cautious Portfolio - One Month On
10/20/201506:12:00DaVita HealthCare Partners Inc. Schedules 3rd Quarter 2015 Investor...
10/12/201506:13:00DaVita to Expand World Headquarters in Downtown Denver
10/09/201518:45:35Initial Statement of Beneficial Ownership (3)
10/09/201506:03:02Current Report Filing (8-k)
10/08/201517:22:00Barbara Allen Named Chief Medical Officer of JSA Medical Group
10/08/201516:35:00DaVita is Clinical Leader in Government Five-Star Ratings
10/08/201506:00:00DaVita Appoints Barbara J. Desoer to Board of Directors
10/07/201516:35:00DaVita Kidney Care Launches the First Ever Medicare Disease-Specific...
10/07/201516:35:00DaVita Kidney Care Launches the Only Medicare Disease-Specific...
10/07/201516:35:00DaVita Kidney Care Launches the First Ever Medicare Disease-Specific...
10/07/201516:32:00DaVita Kidney Care Launches the First Ever Medicare Disease-Specific...

Davita and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations